Reactivation of Bone Lining Cells are Attenuated Over Repeated Anti-sclerostin Antibody Administration

Klibanski A, Adams-Campbell L, Bassford T, Blair SN, Boden SD, Dickersin K, Gifford DR, Glasse L, Goldring SR, Hruska K, Johnson SR (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795. https://doi.org/10.1001/jama.285.6.785

Article  Google Scholar 

Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276–1287. https://doi.org/10.1016/s0140-6736(10)62349-5

CAS  Article  PubMed  PubMed Central  Google Scholar 

The International Osteoporosis Foundation (IOF) (2020) Facts and statictics. Available at https://www.osteoporosisfoundation/facts-statistics

Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis- 2020 update executive summary. Endocr Pract 26:564–570. https://doi.org/10.4158/gl-2020-0524

Article  PubMed  Google Scholar 

Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R (2020) Pharmacological management of osteoporosis in postmenopausal women: an endocrine society guideline update. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa048

Article  PubMed  Google Scholar 

Cosman F (2020) Anabolic therapy and optimal treatment sequences for patients with osteoporosis at high risk for fracture. Endocr Pract 26:777–786. https://doi.org/10.4158/ep-2019-0596

Article  PubMed  Google Scholar 

Compston JE (2007) Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure. Bone 40:1447–1452. https://doi.org/10.1016/j.bone.2006.09.008

CAS  Article  PubMed  Google Scholar 

Lewiecki EM (2020) Romosozumab, clinical trials, and real-world care of patients with osteoporosis. Ann Transl Med 8:974. https://doi.org/10.21037/atm.2020.03.196

Article  PubMed  PubMed Central  Google Scholar 

Ominsky MS, Boyce RW, Li X, Ke HZ (2017) Effects of sclerostin antibodies in animal models of osteoporosis. Bone 96:63–75. https://doi.org/10.1016/j.bone.2016.10.019

CAS  Article  PubMed  Google Scholar 

Ominsky MS, Niu QT, Li C, Li X, Ke HZ (2014) Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody. J Bone Miner Res 29:1424–1430. https://doi.org/10.1002/jbmr.2152

CAS  Article  PubMed  Google Scholar 

McClung MR, Grauer A, Boonen S et al (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370:412–420. https://doi.org/10.1056/NEJMoa1305224

CAS  Article  PubMed  Google Scholar 

Cosman F, Crittenden DB, Adachi JD et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532–1543. https://doi.org/10.1056/NEJMoa1607948

CAS  Article  PubMed  Google Scholar 

Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417–1427. https://doi.org/10.1056/NEJMoa1708322

CAS  Article  PubMed  Google Scholar 

Chavassieux P, Chapurlat R, Portero-Muzy N, Roux JP, Garcia P, Brown JP, Libanati C, Boyce RW, Wang A, Grauer A (2019) Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment. J Bone Miner Res 34:1597–1608. https://doi.org/10.1002/jbmr.3735

CAS  Article  PubMed  Google Scholar 

Kim SW, Lu Y, Williams EA et al (2017) Sclerostin antibody administration converts bone lining cells into active osteoblasts. J Bone Miner Res 32:892–901. https://doi.org/10.1002/jbmr.3038

CAS  Article  PubMed  Google Scholar 

Kalajzic I, Braut A, Guo D, Jiang X, Kronenberg MS, Mina M, Harris MA, Harris SE, Rowe DW (2004) Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 35:74–82. https://doi.org/10.1016/j.bone.2004.03.006

CAS  Article  PubMed  Google Scholar 

Gluhak-Heinrich J, Ye L, Bonewald LF, Feng JQ, MacDougall M, Harris SE, Pavlin D (2003) Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res 18:807–817. https://doi.org/10.1359/jbmr.2003.18.5.807

CAS  Article  PubMed  Google Scholar 

Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70–71. https://doi.org/10.1038/5007

CAS  Article  PubMed  Google Scholar 

Kim SW, Pajevic PD, Selig M, Barry KJ, Yang JY, Shin CS, Baek WY, Kim JE, Kronenberg HM (2012) Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts. J Bone Miner Res 27:2075–2084. https://doi.org/10.1002/jbmr.1665

CAS  Article  PubMed  Google Scholar 

Hong AR, Kim K, Lee JY, Yang JY, Kim JH, Shin CS, Kim SW (2020) Transformation of mature osteoblasts into bone lining cells and RNA sequencing-based transcriptome profiling of mouse bone during mechanical unloading. Endocrinol Metab (Seoul) 35:456–469. https://doi.org/10.3803/EnM.2020.35.2.456

CAS  Article  Google Scholar 

Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17. https://doi.org/10.1002/jbmr.1805

Article  PubMed  Google Scholar 

Matic I, Matthews BG, Wang X, Dyment NA, Worthley DL, Rowe DW, Grcevic D, Kalajzic I (2016) Quiescent bone lining cells are a major source of osteoblasts during adulthood. Stem Cells 34:2930–2942. https://doi.org/10.1002/stem.2474

CAS  Article  PubMed  Google Scholar 

Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137. https://doi.org/10.1210/edrv.21.2.0395

CAS  Article  PubMed  Google Scholar 

Holdsworth G, Greenslade K, Jose J, Stencel Z, Kirby H, Moore A, Ke HZ, Robinson MK (2018) Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists. Bone 107:93–103. https://doi.org/10.1016/j.bone.2017.11.003

CAS  Article  PubMed  Google Scholar 

Chavassieux P, Portero-Muzy N, Roux JP, Garnero P, Chapurlat R (2015) Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women? J Clin Endocrinol Metab 100:4662–4668. https://doi.org/10.1210/jc.2015-2957

CAS  Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif